S
ALXN

SignatureFD’s Alexion Pharmaceuticals ALXN Stock Holding History

SignatureFD’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,502
Closed -$276K – 3305
2021
Q2 		$276K Buy
1,502
+162
+12% +$27.8K 0.01% 541
2021
Q1 		$205K Sell
1,340
-207
-13% -$32K 0.01% 582
2020
Q4 		$242K Buy
1,547
+234
+18% +$30.1K 0.01% 476
2020
Q3 		$150K Sell
1,313
-76
-5% -$8.2K 0.01% 584
2020
Q2 		$156K Buy
1,389
+462
+50% +$49K 0.01% 535
2020
Q1 		$83K Buy
927
+292
+46% +$28.7K 0.01% 710
2019
Q4 		$69K Sell
635
-125
-16% -$13.4K 0.01% 862
2019
Q3 		$74K Sell
760
-62
-8% -$6.99K 0.01% 779
2019
Q2 		$108K Buy
822
+96
+13% +$12.4K 0.01% 598
2019
Q1 		$98K Buy
726
+154
+27% +$19.1K 0.01% 636
2018
Q4 		$56K Buy
572
+25
+5% +$2.96K 0.01% 805
2018
Q3 		$76K Sell
547
-21
-4% -$2.63K 0.01% 740
2018
Q2 		$71K Buy
568
+272
+92% +$31.8K 0.01% 739
2018
Q1 		$33K Buy
+296
New +$35.4K ﹤0.01% 889
2016
Q4 		– Sell
-479
Closed -$59K – 1384
2016
Q3 		$59K Buy
479
+164
+52% +$21.1K 0.01% 495
2016
Q2 		$37K Sell
315
-8
-2% -$1.14K 0.01% 548
2016
Q1 		$45K Buy
323
+61
+23% +$8.96K 0.01% 459
2015
Q4 		$50K Buy
262
+172
+191% +$30K 0.01% 369
2015
Q3 		$14K Buy
90
+72
+400% +$13.1K ﹤0.01% 616
2015
Q2 		$3K Buy
18
+2
+13% +$345 ﹤0.01% 855
2015
Q1 		$3K Buy
+16
New +$2.9K ﹤0.01% 778

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

SignatureFD's ALXN Position: Q3 2021 in Review

SignatureFD sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,502 shares — an estimated $276K sold.

SignatureFD first reported a position in ALXN in Q1 2015 and held it in 21 quarters. The position peaked at $276K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • SignatureFD reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • SignatureFD sold 1,502 Alexion Pharmaceuticals shares in Q3 2021, an estimated $276K.
  • SignatureFD first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 21 quarters.
  • SignatureFD's Alexion Pharmaceuticals position peaked at $276K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on SignatureFD's 13F filing for Q3 2021, filed 28 Oct 2021.